Phosphofructokinase (ATP:D-fructose-6phos-phate 1-phosphotransferase, EC 2.7.1.11) was partially purified the livers of genetically diabetic mice (C57BL/Ksj-db) and their lean littermates (C57BL/KsJ). These genetically diabetic mice have been shown to be hyperglucagonemic and to exhibit symptoms resembling those of maturity-onset diabetes in humans. Two isozymes of phosphofructokinase were obtained after DEAE-Sephadex chromatography of extracts of livers from either normal or diabetic animals. One of these isozymes, peak II, from the genetically diabetic mice was shown to be more sensitive to ATP inhibition at physiological pH than the peak II isozyme from the normal animals. In addition, the peak II isozyme from the diabetic mice exhibited decreased affinity for fructose 6-phosphate. The (4) . Enhanced gluconeogenesis appears to be a major factor in the hyperglycemia of diabetic mice. Studies of gluconeogenic fluxes and metabolite levels in diabetic mice indicate that the increased liver gluconeogenesis is likely to be due to a facilitation of the fructose 1,6-bisphosphatase (D-fructose-1,6-bisphosphate 1-phosphohydrolase, EC 3.1.3.11) reaction or a restraint of the phosphofructokinase (ATP:D-fructose-6-phosphate 1-phosphotransferase, EC 2.7.1.11) reaction or both (5). Studies on gluconeogenic rates in isolated rat liver cells also led to the proposal that glucagon enhances gluconeogenesis and inhibits glycolysis at the site of fructose 1,6-bisphosphatase and phosphofructokinase (6).
isozyme from the diabetic mice exhibited decreased affinity for fructose 6-phosphate. The altered kinetic properties of phosphofructokinase from diabetic animals are markedly similar to those recently reported for liver phosphofructokinase isolated from normal animals after glucagon treatment. Our results suggest that increased glucagon levels in diabetes may lead to altered regulation of phosphofructokinase in this disease. During the past few years an increasing number of studies have used the genetically diabetic mouse (C57BL/KsJ-db) which exhibits symptoms similar to those of human maturity-onset diabetes. These animals are characterized by obesity, hyperphagia, and marked hyperglycemia. Plasma insulin concentration is increased at an early age but decreases to near normal levels after 3 months of age (for review, see refs. 1 and 2). Levels of immunoreactive glucagon are increased in the genetically diabetic mouse (3) . This hormonal imbalance agrees with present (but controversial) views that, in addition to a lack of effective insulin, absolute or relative glucagon excess is one of the major causes of hyperglycemia in the diabetic state (4) . Enhanced gluconeogenesis appears to be a major factor in the hyperglycemia of diabetic mice. Studies of gluconeogenic fluxes and metabolite levels in diabetic mice indicate that the increased liver gluconeogenesis is likely to be due to a facilitation of the fructose 1,6-bisphosphatase (D-fructose-1,6-bisphosphate 1-phosphohydrolase, EC 3.1.3.11) reaction or a restraint of the phosphofructokinase (ATP:D-fructose-6-phosphate 1-phosphotransferase, EC 2.7.1.11) reaction or both (5) . Studies on gluconeogenic rates in isolated rat liver cells also led to the proposal that glucagon enhances gluconeogenesis and inhibits glycolysis at the site of fructose 1,6-bisphosphatase and phosphofructokinase (6) .
With this background it appeared to us that a comparative study of both phosphofructokinase and fructose 1,6-bisphosphatase from the livers of C57BL/KsJ normal and diabetic hyperglucagonemic mice could provide an insight into the mode of action of glucagon at the metabolic steps catalyzed by the above enzymes.
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A previous study of fructose 1,6-bisphosphatase isolated from the livers of diabetic mice and from the normal controls showed no difference in either molecular or enzymatic properties between the two purified enzymes (7) . In this communication we show that phosphofructokinase isolated from the livers of diabetic mice is more sensitive to ATP inhibition than is the enzyme isolated from the livers of normal controls and therefore may represent a physiologically less active form of phosphofructokinase. These results are entirely in accord with three recent independent reports which have indicated decreased liver phosphofructokinase activity after either administration of glucagon to rats (8) or addition of glucagon to isolated rat hepatocytes (9, 10 Normal C57BL/KsJ (misty m+/m+, or m+/db+) and genetically diabetic C57BL/KsJ-db (db+/db+) mice were obtained at 7-8 weeks of age from The Jackson Laboratory (Bar Harbor, ME). The animals were housed in plastic cages in a Puffer-Hubbard Environator chamber maintained at 21°C with a 12-hr light (0800-2000)/12-hr dark (2000-0800) cycle. They were fed Purina rat chow and water ad lib. Animals were routinely sacrificed in the morning (0800-1000) by cervical dislocation. All db+/db+ animals used in this study were [19] [20] [21] [22] [23] [24] [25] weeks old.
Phosphofructokinase activity was determined spectrophotometrically at 300C as described by Kemp (11) . Enzyme activity at pH 8.2 was measured in the following 3-ml reaction mixture: 25 mM glycylglycine; 25 mM disodium f3-glycerophosphate; 1 mM EDTA; 6 mM MgSO4; 3 mM (NH4)2SO4; 1 mM fructose 6-phosphate; 1 mM ATP; 1 mM dithiothreitol; 0.22 mM NADH; 1.8 units of aldolase; and 0.9 unit each of a-glycerophosphate dehydrogenase and triose-phosphate isomerase. For kinetic studies, enzyme activity at pH 7.45 was measured in the presence of 50 mM Tris-HCI, 150 mM KCl, 1 mM EDTA, 1 mM dithiothreitol, NADH and auxiliary enzymes as above, ATP, and fructose 6-phosphate as indicated. In these studies, MgCl2 was maintained at 5 mM in excess of ATP. For studies at pH 7.45, phosphofructokinase and the auxiliary enzymes were dialyzed extensively against 25 mM glycylglyAbbreviation: U, unit of enzyme activity.
Proc. Natl. Acad. Sci. USA 77 (1980) cine/25 mM disodium f3-glycerophosphate/1 mM EDTA/0.5 mM dithiothreitol/0.05 mM ATP at pH 7.4 prior to use. One unit (U) of activity is defined as that amount of enzyme that catalyzes the conversion of 1 ,umol of fructose 6-phosphate to fructose 1,6-bisphosphate per min at 30'C. In all experiments, the reaction was started by the addition of fructose 6-phosphate after 2-4 min of preincubation at 30'C. Rates were determined 8-12 min after the reaction was started.
Protein determinations were performed by the biuret procedure (12) or by the Coomassie blue-binding method of Bradford (13) . Zone electrophoresis was performed at 40C as described (14) . The DEAE-Sephadex columns used to separate the phosphofructokinase isozymes were equilibrated with an ATP-containing buffer (see Results) until the absorbance at 260 nm became constant and the pH was that of the starting buffer.
RESULTS AND DISCUSSION Initial studies designed to purify mouse liver phosphofructokinase utilized techniques developed previously for the purification of rabbit liver phosphofructokinase (14, 15) . However, it became apparent that there were major differences in the behavior of rabbit and mouse liver phosphofructokinases in ammonium sulfate precipitation and in DEAE-Sephadex chromatographic steps. These differences can be attributed to isozyme content: rabbit liver contains only the B4 isozyme (16) whereas mouse liver contains more than one isozyme. The purification method described below was developed in order to prevent the loss of any of the mouse liver isozymes and to achieve their separation for kinetic analysis.
Livers from five C57BL/KsJ normal or three diabetic mice were minced with scissors and homogenized in a SorvallOmni-Mixer at full speed for 45 sec in 2 vol of ice-cold 50 mM Tris phosphate, pH 8/30 mM KF/10 mM EDTA/0.1 mM ATP/0. 1 mM dithiothreitol (buffer A); then an additional vol of buffer A was added and the extract was again homogenized for 45 sec. The homogenate was centrifuged at 33,000 X g for 30 min at 4°C. The precipitate was discarded and the supernatant was filtered through glass wool. The pH of the supernatant was adjusted to 8.5 with 1 M Tris base. Extracts of either normal or diabetic mice livers had specific activities of 0.022-0.026 U/mg and yielded 1.6-2 U/g wet weight. The extract was brought to 580C with constant stirring in a 75-80°C bath and then transferred to a 580C bath for 3 min. The solution was cooled on ice to less than 300C and then centrifuged as above. Recovery of phosphofructokinase at this step was 80-95% and the specific activity was about 0.07 U/mg.
To the clear supernatant, 32.6 g of ammonium sulfate was added per 100 ml of solution, and the solution was then stirred for 45 min at 40C. The suspension was centrifuged at 17,000 X g for 30 min and the supernatant was discarded. The precipitate was dissolved in a small volume (0.2-0.5 ml) of 20 mM Tris-HCI, pH 7.5/2 mM EDTA/5 mM (NH4)2SO4/6 mM Na citrate/0.1 mM ATP/0.1 mM fructose 1,6-bisphosphate/0.5 mM dithiothreitol (buffer B). The somewhat turbid solution was dialyzed at 40C against several changes of buffer B. Recovery of phosphofructokinase after this step was 70-80%, and the specific activity was 0.16-0.35 U/mg. The dialyzed enzyme was diluted with buffer B to a protein concentration of approximately 5 mg/ml and applied to a 1.5 X 24 cm column of DEAE-Sephadex A-25 previously equilibrated with buffer B. This entire chromatographic step was performed at room temperature.
The column was washed with buffer B until the absorbance at 280 nm due to protein eluate was less than 0.1. The column was eluted with a linear gradient of (NH4)2SO4 (5-250mM in 200 ml) in buffer B. Two peaks of phosphofructokinase activity were found (Fig. 1) . These peaks eluted at approximately 30 and 65 mM (NH4)2SO4 and were designated phosphofructokinase peak I and peak II, respectively. The activity eluting in these two peaks routinely accounted for 70-80% of the total activity applied to the column. Cellulose acetate gel electrophoresis (16) indicated that these two peaks corresponded to the two bands observed upon electrophoresis of C57BL/KsJ mice liver extracts. Peak I and II were concentrated by ultrafiltration. The specific activity of peak I was less than 10 U/mg protein; the specific activity of peak II was 30-60 U/mg protein. Both peaks were shown to be free of fructose-1,6-bisphosphatase, fructose-6-phosphate isomerase, and ATPase.
Peaks I and II were analyzed by cellulose acetate gel electrophoresis under conditions known to differentiate between the different isozyme forms of phosphofructokinase [i.e., A4, B4 or A2B2 (16, 17) ]. In addition, the sensitivities of the two peaks to ATP inhibition at pH 7.45 and 1 mM fructose 6-phosphate were studied. Peak I had an electrophoretic mobility similar to that of an A2B2 isozyme and was relatively insensitive to ATP inhibition (50% inhibition at about 2 mM ATP). Peak II was more sensitive to ATP inhibition (0.65 mM required to achieve 50% inhibition), and it exhibited an electrophoretic mobility characteristic of a liver type isozyme (B4) (16, 17) .
Dunaway and Weber (18) have shown that two forms of phosphofructokinase exist in rat liver. Dunaway et al. (19) suggest that the form eluting first from a DEAE-cellulose column originates in the nonparenchymal cells and the type eluting second originates from the parenchymal cells (19) . Based on these findings and our results suggesting that mouse liver phosphofructokinase peak II is similar in electrophoretic and kinetic properties to the single isozyme found in rabbit liver, it seems reasonable to assume that phosphofructokinase peak I is derived from nonparenchymal cells and that peak II represents the major hepatic form of the enzyme in mouse liver. ml/hr, and 3-ml fractions were collected. Activity at pH 8 it is the hepatic isozyme rather than the enzyme from nonparenchymal cells which is believed to be under hormonal control (20) .
Phosphofructokinase peak II obtained from normal and from genetically diabetic mice were characterized with respect to sensitivity to ATP inhibition at pH 7.45.
The phosphofructokinase peak II from diabetic mice was significantly more sensitive to inhibition by ATP (Fig. 2) . The concentration of ATP required for 50% inhibition was 0.40 mM for the diabetic and 0.65 mM for normal controls. The absolute amount of phosphofructokinase added to each assay was standardized by using amounts of phosphofructokinase from normal or diabetic mice which gave equal activity at pH 8.2. Results similar to those illustrated in Fig. 2 were obtained in several independent experiments using different preparations of peak II from normal and diabetic mice, although some variation in the maximal V/V4,X values (0. 10-0.19) was observed.
These data showing ATP inhibition of phosphofructokinase from normal and diabetic mice livers are strikingly similar to those of ATP inhibition of phosphofructokinase from livers of control and glucagon-treated rats (cf. figure 2 in ref. 8) . The latter study (8) 
